M.J. Butt, A.F. Tarantal, D.F. Jimenez, D.G. Matsell 

Slides:



Advertisements
Similar presentations
Stem cells in the embryonic kidney
Advertisements

Volume 62, Issue 1, Pages (July 2002)
Thomas Kirchner, Thomas Brabletz  The American Journal of Pathology 
Volume 77, Issue 6, Pages (March 2010)
Volume 68, Issue 3, Pages (September 2005)
Persistent rejection of peritubular capillaries and tubules is associated with progressive interstitial fibrosis  Akira Shimizu, Kazuhiko Yamada, David.
Volume 60, Issue 1, Pages (July 2001)
Osteopontin expression in human crescentic glomerulonephritis
Volume 56, Issue 3, Pages (September 1999)
Ontogeny of CD24 in the human kidney
Volume 78, Issue 4, Pages (August 2010)
Volume 81, Issue 9, Pages (May 2012)
Volume 54, Issue 3, Pages (September 1998)
Volume 62, Issue 1, Pages (July 2002)
Volume 124, Issue 1, Pages (January 2003)
Volume 67, Issue 3, Pages (March 2005)
J.M. Henderson, S. al-Waheeb, A. Weins, S.V. Dandapani, M.R. Pollak 
Fetal rhesus monkey model of obstructive renal dysplasia
IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy  J.-A. Moon,
Volume 70, Issue 7, Pages (October 2006)
Volume 81, Issue 9, Pages (May 2012)
Volume 62, Issue 6, Pages (December 2002)
The renal segmental distribution of claudins changes with development
Hyperlipidemia aggravates renal disease in B6.ROP Os/+ mice
Volume 58, Issue 4, Pages (October 2000)
Volume 83, Issue 4, Pages (April 2013)
Volume 75, Issue 10, Pages (May 2009)
Comparative efficacy of renal preservation solutions to limit functional impairment after warm ischemic injury  N. Ahmad, J.R. Pratt, D.J. Potts, J.P.A.
Volume 54, Issue 3, Pages (September 1998)
Volume 57, Issue 2, Pages (October 2000)
Volume 54, Issue 1, Pages (July 1998)
Michel Le Hir, Valérie Besse-Eschmann  Kidney International 
Volume 69, Issue 1, Pages (January 2006)
Volume 81, Issue 12, Pages (June 2012)
The renal lesions that develop in neonatal mice during angiotensin inhibition mimic obstructive nephropathy  Yoichi Miyazaki, Shinya Tsuchida, Agnes Fogo,
Volume 63, Issue 2, Pages (February 2003)
Volume 58, Issue 2, Pages (August 2000)
Volume 57, Issue 3, Pages (March 2000)
Treatment of chronic tubulointerstitial disease: A new concept
Volume 78, Issue 6, Pages (September 2010)
Volume 70, Issue 10, Pages (November 2006)
Yongji Wang, Megan L. Borchert, Hector F. DeLuca  Kidney International 
Volume 67, Issue 2, Pages (February 2005)
Volume 75, Issue 2, Pages (January 2009)
Nephrotic syndrome associated with hemophagocytic syndrome
Volume 63, Issue 4, Pages (April 2003)
Volume 59, Issue 3, Pages (March 2001)
Neil J. Paloian, Elizabeth M. Leaf, Cecilia M. Giachelli 
Yuan-Yow Chiou, Chi-Chang Shieh, Hong-Lin Cheng, Ming-Jer Tang 
Volume 65, Issue 2, Pages (February 2004)
Volume 77, Issue 4, Pages (February 2010)
Volume 73, Issue 9, Pages (May 2008)
Robert L. Chevalier, Michael S. Forbes, Barbara A. Thornhill 
Volume 60, Issue 3, Pages (September 2001)
Volume 82, Issue 2, Pages (July 2012)
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis  H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo 
Volume 57, Issue 6, Pages (June 2000)
Nestin expression in the kidney with an obstructed ureter
M.-J. Wu, M.-C. Wen, Y.-T. Chiu, Y.-Y. Chiou, K.-H. Shu, M.-J. Tang 
CD4+ T cells: a potential player in renal fibrosis
Tubulointerstitial damage and progression of renal failure
Volume 57, Issue 5, Pages (May 2000)
Volume 69, Issue 11, Pages (June 2006)
Douglas G. Matsell, Amy Mok, Alice F. Tarantal  Kidney International 
Kirk J. Maurer, Robert P. Marini, James G. Fox, Arlin B. Rogers 
Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure  D.W. Johnson, B. Pat, D.A. Vesey, Z.
Volume 76, Issue 8, Pages (October 2009)
A nest in renal fibrosis?
Volume 74, Issue 8, Pages (October 2008)
Alex B. Magil, Kathryn Tinckam  Kidney International 
Presentation transcript:

Collecting duct epithelial–mesenchymal transition in fetal urinary tract obstruction  M.J. Butt, A.F. Tarantal, D.F. Jimenez, D.G. Matsell  Kidney International  Volume 72, Issue 8, Pages 936-944 (October 2007) DOI: 10.1038/sj.ki.5002457 Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 1 Immunohistochemical features of fetal urinary tract obstruction. Cortex and medulla of control and obstructed fetal kidneys demonstrating (a) SMA immunoreactivity in the expanded interstitium, in periglomerular and peritubular collars of the cortex, and in peritubular collars of the medulla following obstruction. In the control kidney, strong SMA expression can be seen in the medial layer of arterioles with weaker expression in the renal capsule. (b) Disruption of E-cadherin immunoreactivity in the obstructed kidney highlighted by loss of distinct interepithelial localization (arrowheads) and diffuse cytoplasmic immunoreactivity (arrow). (c) Vim immunoreactivity in the expanded interstitium of both obstructed cortex and medulla. (g, glomerulus; d, collecting duct; *, interstitium). Bars=(a) 100 μm and (b and c) 50 μm. Kidney International 2007 72, 936-944DOI: (10.1038/sj.ki.5002457) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 2 mRNA expression in obstructed fetal kidneys. Quantitative real-time RT-PCR demonstrates the downregulation of E-cadherin and upregulation of Vim gene expression in obstructed versus control and contralateral kidneys. Of note, these differences were more pronounced in the medulla than in the cortex. *P<0.05, obstructed versus control. Kidney International 2007 72, 936-944DOI: (10.1038/sj.ki.5002457) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 3 Normal fetal medullary CD. (a) Normal medullary CD epithelium displays AQP2, E-cadherin, and CK immunoreactivity and absent Vim immunoreactivity (arrows demarcate epithelial layer). (b) Co-localization of SMA and CAII immunoreactivity in AQP2-negative epithelia (from a) of the normal CD (arrowheads highlight examples of SMA+/CAII+/AQP2- subpopulation). Bar=25 μm. Kidney International 2007 72, 936-944DOI: (10.1038/sj.ki.5002457) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 4 Peritubular collar formation in obstructed fetal CD. Obstruction of the fetal kidney results in CD injury that can be classified by the extent of SMA immunoreactivity in the peritubular cellular collars, ranging from ‘mild’ with limited peritubular SMA immunoreactivity (arrowhead) to ‘severe’ with full, circumferential collars (arrows). Bar=25 μm. Kidney International 2007 72, 936-944DOI: (10.1038/sj.ki.5002457) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 5 Loss of epithelial and gain of mesenchymal characteristics. (a). In the obstructed fetal kidney, the medullary CD epithelium demonstrates disruption of interepithelial E-cadherin immunoreactivity (arrowheads) with concomitant de novo expression of basolateral Vim (arrows). (b). In addition, in the obstructed kidney there is a decrease in AQP2 immunoreactivity in the epithelium of dilated CDs (*) versus adjacent normal and control CDs. (c). Similar to Vim, the obstructed CD epithelium exhibits increased basolateral expression of fibroblast surface protein (FSP) (arrows) associated with SMA collar formation. Bars=(a and c) 25 μm and (b) 100 μm. Kidney International 2007 72, 936-944DOI: (10.1038/sj.ki.5002457) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 6 Proliferation of the obstructed CD epithelial cells and surrounding interstitium. (a) Nuclear Ki-67 immunoreactivity in selected obstructed CDs showing cellular proliferation in AQP2+principal cells (arrowheads) and peritubular interstitium (arrow) compared with control CDs. (b) Comparison of Ki-67 immunoreactivity in control and obstructed CDs shows increased number of Ki-67 positive interstitial cells adjacent to moderately to severely dilated CDs, but no significant increase in Ki-67 positive CD epithelial cells. Results are expressed as the percentage of Ki-67 positive cells per number of epithelial cells comprising the circumference of the CD. *P<0.05 versus control. Bar=25 μm. Kidney International 2007 72, 936-944DOI: (10.1038/sj.ki.5002457) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 7 Depletion of SMA+/CAII+ cells in obstructed fetal CDs. (a) In the epithelia of the obstructed, dilated CDs there is a loss of CAII+ cells compared with control CDs. (b) The number of CAII+ cells in the obstructed CDs, regardless of severity, was significantly reduced when compared with control and contralateral CDs. *P<0.01 versus control and contralateral. (c) TUNEL analysis of obstructed and control kidneys indicates infrequent apoptotic events (arrows) in the medulla and rarely in the CD epithelium. Bars=(a) 50 μm and (c) 25 μm. Kidney International 2007 72, 936-944DOI: (10.1038/sj.ki.5002457) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 8 Disruption of basement membrane and evidence of cellular migration in obstructed fetal CDs. (a) In the normal CD epithelial basement membrane, there is thin, linear, circumferential, and homogeneous type IV collagen immunoreactivity (arrowhead). In the obstructed CD, the basement membrane type IV collagen (Coll IV) immunoreactivity is diffuse and thickened, particularly in areas of peritubular SMA expression (arrow), and is absent in other areas. (b) In the obstructed CD, CAII immunoreactivity indicates migration of SMA+/CAII+ cells (arrowheads) into the interstitial space and the SMA+ peritubular collar, and, as in (c) outside of the normal plane of the epithelial cell layer. (d) In the transitioning cells, E-cadherin expression persists in the interepithelial junctions but becomes diffusely cytoplasmic suggesting disruption of the cadherin junction complex. Bar=(a–d) 25 μm. Kidney International 2007 72, 936-944DOI: (10.1038/sj.ki.5002457) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 9 Paradigm of progenitor differentiation in response to fetal urinary tract obstruction. With urinary tract obstruction, progenitor cells within the CD epithelium may respond to tubular injury in a number of different ways, including proliferating and expanding of the principal cell population to maintain epithelial integrity, and/or committing to a myofibroblastic phenotype through EMT and forming peritubular collars in response to increased intraluminal pressure. Kidney International 2007 72, 936-944DOI: (10.1038/sj.ki.5002457) Copyright © 2007 International Society of Nephrology Terms and Conditions